Atherosclerosis Research Unit, Institute of Clinical Medicine and Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
Atherosclerosis Research Unit, Institute of Clinical Medicine and Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.
Atherosclerosis. 2017 Aug;263:7-14. doi: 10.1016/j.atherosclerosis.2017.05.019. Epub 2017 May 18.
Individuals with type 1 diabetes mellitus are at high risk of developing atherosclerotic cardiovascular disease, but the underlying mechanisms by which type 1 diabetes accelerates atherosclerosis remain unknown. Increased retention of low-density lipoprotein (LDL) in atherosclerosis-prone sites of the diabetic vascular wall has been suggested, but direct evidence is lacking. In the present study, we investigated whether retention of LDL is increased in atherosclerotic-prone areas using a murine model of type 1 diabetes.
Fluorescently-labeled human LDL from healthy non-diabetic individuals was injected into diabetic Ins2Akita mice and non-diabetic, wild-type littermates. The amount of retained LDL after 24 h was quantified by fluorescence microscopy of cryosections and by scans of en face preparations. Vascular gene expression in the inner curvature of the aortic arch was analyzed by microarray and quantitative polymerase chain reaction.
LDL retention was readily detected in atherosclerosis-prone areas of the aortic arch being located in both intimal and medial layers. Quantitative microscopy revealed 8.1-fold more retained LDL in type 1 diabetic mice compared to wild-type mice. These findings were confirmed in independent experiments using near-infrared scanning of en face preparations of the aorta. Diabetic status did not affect arterial expression of genes known to be involved in LDL retention.
Type 1 diabetes increases the ability of the vascular wall to retain LDL in mice. These changes could contribute to the increased atherosclerotic burden seen in type 1 diabetic patients.
1 型糖尿病患者发生动脉粥样硬化性心血管疾病的风险很高,但 1 型糖尿病加速动脉粥样硬化的潜在机制尚不清楚。有人提出,糖尿病血管壁易发生动脉粥样硬化的部位中,低密度脂蛋白(LDL)的滞留增加,但缺乏直接证据。在本研究中,我们使用 1 型糖尿病的小鼠模型,研究了 LDL 滞留是否增加在易发生动脉粥样硬化的部位。
将来自健康非糖尿病个体的荧光标记人 LDL 注入 1 型糖尿病 Ins2Akita 小鼠和非糖尿病野生型同窝仔鼠。通过冷冻切片荧光显微镜和正面准备物扫描定量检测 24 小时后滞留的 LDL 量。通过微阵列和定量聚合酶链反应分析主动脉弓内弯曲处的血管基因表达。
LDL 滞留很容易在主动脉弓易发生动脉粥样硬化的部位检测到,位于内膜和中膜层。定量显微镜显示,1 型糖尿病小鼠中滞留的 LDL 比野生型小鼠多 8.1 倍。这些发现通过使用主动脉正面准备物的近红外扫描的独立实验得到了证实。糖尿病状态并不影响已知参与 LDL 滞留的基因在动脉中的表达。
1 型糖尿病增加了小鼠血管壁在 LDL 中的滞留能力。这些变化可能导致 1 型糖尿病患者中动脉粥样硬化负担的增加。